India Pneumonia Vaccine Market (2025-2031) Outlook | Revenue, Forecast, Companies, Trends, Share, Value, Analysis, Industry, Size & Growth

Name: India Pneumonia Vaccine Market (2025-2031) | Trends, Outlook & Forecast
Creator: 6Wresearch
License: https://www.6wresearch.com/privacy-policy
Keywords: Pneumonia Vaccine Market, India Pneumonia Vaccine Market, India Pneumonia Vaccine Market Revenues, India Pneumonia Vaccine Market Share, India Pneumonia Vaccine Market Size, India Pneumonia Vaccine Market Outlook, India Pneumonia Vaccine Market Report, India Pneumonia Vaccine Market Competition, India Pneumonia Vaccine Market Overview, India Pneumonia Vaccine Market Trends, India Pneumonia Vaccine Market Forecast

Market Forecast By Vaccine Type (Pneumococcal Conjugate Vaccine, Pneumococcal Polysaccharide Vaccine), By Product Type (Prevnar 13, Synflorix, Pneumovax 23), By Sector (Public, Private), By Distribution Channel (Distribution Partner Companies, Non-governmental Organizations (NGO), Government Authorities) And Competitive Landscape

Product Code: ETC340824	Publication Date: Aug 2022	Updated Date: Nov 2025	Product Type: Market Research Report
Publisher: 6Wresearch	Author: Ravi Bhandari	No. of Pages: 75	No. of Figures: 35	No. of Tables: 20

India Pneumonia Vaccine Market Top 5 Importing Countries and Market Competition (HHI) Analysis

India`s import shipments of pneumonia vaccines in 2024 saw a significant shift in concentration, with the Herfindahl-Hirschman Index (HHI) indicating a move from moderate to high concentration. The top countries exporting to India included the USA, Denmark, China, Sweden, and South Korea. Despite a negative Compound Annual Growth Rate (CAGR) of -22.7% from 2020 to 2024, the growth rate in 2024 alone plummeted by -49.05%. This data suggests a challenging market environment for pneumonia vaccine imports in India, with notable changes in concentration and declining growth rates.

India Pneumonia Vaccine Market Top 5 Importing Countries and Market Competition (HHI) Analysis

India Pneumonia Vaccine Market Synopsis

The pneumonia vaccine market in India is driven by healthcare initiatives, disease prevention efforts, and immunization campaigns. The outlook depends on healthcare infrastructure, awareness programs, and government policies. Growth factors include disease prevalence, the need for childhood immunization, and advancements in vaccine technology. Challenges involve vaccine distribution, affordability, and addressing public misconceptions. Stakeholders need to collaborate to ensure effective vaccine access, education, and disease prevention.

Drivers of the market

The pneumonia vaccine market in India is influenced by various drivers. The government`s focus on immunization programs, healthcare infrastructure development, and awareness campaigns contribute to the demand for pneumonia vaccines. Pneumonia remains a significant public health concern, especially among children and the elderly, driving the need for preventive measures. Collaboration between public and private sectors, advancements in vaccine technology, and efforts to improve accessibility further boost the market`s growth.

Challenges of the Market

India pneumonia vaccine market outlook is essential for public health. Challenges include ensuring equitable vaccine distribution, particularly in remote areas. Overcoming vaccine hesitancy and maintaining cold chain logistics for vaccine delivery pose ongoing challenges. Additionally, developing cost-effective vaccines that cater to the diverse population and strain variations is crucial.

Covid-19 Impact on the Market

The India pneumonia vaccine market has gained importance in the context of public health efforts to combat respiratory infections. Pneumonia vaccines play a crucial role in preventing pneumonia-related illnesses, especially in vulnerable populations. The market experienced fluctuations during the COVID-19 pandemic, with healthcare resources diverted towards pandemic response. As healthcare systems stabilize, the focus on preventive vaccines is expected to resume. Stakeholders will emphasize accessibility, immunization campaigns, and awareness initiatives to address pneumonia-related health challenges.

Key Players of the Market

The India pneumonia vaccine market is likely to see growth as healthcare awareness and vaccination programs increase. Pneumonia vaccines are crucial for preventing respiratory infections. Major players in this market include Serum Institute of India and Bharat Biotech International Limited.

Key Highlights of the Report:

India Pneumonia Vaccine Market Outlook
Market Size of India Pneumonia Vaccine Market, 2024
Forecast of India Pneumonia Vaccine Market, 2031
Historical Data and Forecast of India Pneumonia Vaccine Revenues & Volume for the Period 2021-2031
India Pneumonia Vaccine Market Trend Evolution
India Pneumonia Vaccine Market Drivers and Challenges
India Pneumonia Vaccine Price Trends
India Pneumonia Vaccine Porter's Five Forces
India Pneumonia Vaccine Industry Life Cycle
Historical Data and Forecast of India Pneumonia Vaccine Market Revenues & Volume By Vaccine Type for the Period 2021-2031
Historical Data and Forecast of India Pneumonia Vaccine Market Revenues & Volume By Pneumococcal Conjugate Vaccine for the Period 2021-2031
Historical Data and Forecast of India Pneumonia Vaccine Market Revenues & Volume By Pneumococcal Polysaccharide Vaccine for the Period 2021-2031
Historical Data and Forecast of India Pneumonia Vaccine Market Revenues & Volume By Product Type for the Period 2021-2031
Historical Data and Forecast of India Pneumonia Vaccine Market Revenues & Volume By Prevnar 13 for the Period 2021-2031
Historical Data and Forecast of India Pneumonia Vaccine Market Revenues & Volume By Synflorix for the Period 2021-2031
Historical Data and Forecast of India Pneumonia Vaccine Market Revenues & Volume By Pneumovax 23 for the Period 2021-2031
Historical Data and Forecast of India Pneumonia Vaccine Market Revenues & Volume By Sector for the Period 2021-2031
Historical Data and Forecast of India Pneumonia Vaccine Market Revenues & Volume By Public for the Period 2021-2031
Historical Data and Forecast of India Pneumonia Vaccine Market Revenues & Volume By Private for the Period 2021-2031
Historical Data and Forecast of India Pneumonia Vaccine Market Revenues & Volume By Distribution Channel for the Period 2021-2031
Historical Data and Forecast of India Pneumonia Vaccine Market Revenues & Volume By Distribution Partner Companies for the Period 2021-2031
Historical Data and Forecast of India Pneumonia Vaccine Market Revenues & Volume By Non-governmental Organizations (NGO) for the Period 2021-2031
Historical Data and Forecast of India Pneumonia Vaccine Market Revenues & Volume By Government Authorities for the Period 2021-2031
India Pneumonia Vaccine Import Export Trade Statistics
Market Opportunity Assessment By Vaccine Type
Market Opportunity Assessment By Product Type
Market Opportunity Assessment By Sector
Market Opportunity Assessment By Distribution Channel
India Pneumonia Vaccine Top Companies Market Share
India Pneumonia Vaccine Competitive Benchmarking By Technical and Operational Parameters
India Pneumonia Vaccine Company Profiles
India Pneumonia Vaccine Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

How does 6Wresearch market report help businesses in making strategic decisions?

Do you also provide customisation in the market study?

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 India Pneumonia Vaccine Market Overview

3.1 India Country Macro Economic Indicators

3.2 India Pneumonia Vaccine Market Revenues & Volume, 2021 & 2031F

3.3 India Pneumonia Vaccine Market - Industry Life Cycle

3.4 India Pneumonia Vaccine Market - Porter's Five Forces

3.5 India Pneumonia Vaccine Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F

3.6 India Pneumonia Vaccine Market Revenues & Volume Share, By Product Type, 2021 & 2031F

3.7 India Pneumonia Vaccine Market Revenues & Volume Share, By Sector, 2021 & 2031F

3.8 India Pneumonia Vaccine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

4 India Pneumonia Vaccine Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing awareness about the importance of vaccination in preventing pneumonia

4.2.2 Rising government initiatives to promote immunization programs

4.2.3 Growing healthcare infrastructure in India

4.3 Market Restraints

4.3.1 High cost associated with pneumonia vaccines

4.3.2 Limited access to vaccines in remote areas

4.3.3 Challenges in cold chain logistics for vaccine distribution

5 India Pneumonia Vaccine Market Trends

6 India Pneumonia Vaccine Market, By Types

6.1 India Pneumonia Vaccine Market, By Vaccine Type

6.1.1 Overview and Analysis

6.1.2 India Pneumonia Vaccine Market Revenues & Volume, By Vaccine Type, 2021-2031F

6.1.3 India Pneumonia Vaccine Market Revenues & Volume, By Pneumococcal Conjugate Vaccine, 2021-2031F

6.1.4 India Pneumonia Vaccine Market Revenues & Volume, By Pneumococcal Polysaccharide Vaccine, 2021-2031F

6.2 India Pneumonia Vaccine Market, By Product Type

6.2.1 Overview and Analysis

6.2.2 India Pneumonia Vaccine Market Revenues & Volume, By Prevnar 13, 2021-2031F

6.2.3 India Pneumonia Vaccine Market Revenues & Volume, By Synflorix, 2021-2031F

6.2.4 India Pneumonia Vaccine Market Revenues & Volume, By Pneumovax 23, 2021-2031F

6.3 India Pneumonia Vaccine Market, By Sector

6.3.1 Overview and Analysis

6.3.2 India Pneumonia Vaccine Market Revenues & Volume, By Public, 2021-2031F

6.3.3 India Pneumonia Vaccine Market Revenues & Volume, By Private, 2021-2031F

6.4 India Pneumonia Vaccine Market, By Distribution Channel

6.4.1 Overview and Analysis

6.4.2 India Pneumonia Vaccine Market Revenues & Volume, By Distribution Partner Companies, 2021-2031F

6.4.3 India Pneumonia Vaccine Market Revenues & Volume, By Non-governmental Organizations (NGO), 2021-2031F

6.4.4 India Pneumonia Vaccine Market Revenues & Volume, By Government Authorities, 2021-2031F

7 India Pneumonia Vaccine Market Import-Export Trade Statistics

7.1 India Pneumonia Vaccine Market Export to Major Countries

7.2 India Pneumonia Vaccine Market Imports from Major Countries

8 India Pneumonia Vaccine Market Key Performance Indicators

8.1 Percentage increase in vaccination coverage among vulnerable populations

8.2 Number of government immunization campaigns conducted annually

8.3 Rate of adoption of new, more cost-effective vaccine technologies

8.4 Number of healthcare facilities offering pneumonia vaccination services

8.5 Level of public-private partnerships in vaccine distribution and awareness campaigns

9 India Pneumonia Vaccine Market - Opportunity Assessment

9.1 India Pneumonia Vaccine Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F

9.2 India Pneumonia Vaccine Market Opportunity Assessment, By Product Type, 2021 & 2031F

9.3 India Pneumonia Vaccine Market Opportunity Assessment, By Sector, 2021 & 2031F

9.4 India Pneumonia Vaccine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

10 India Pneumonia Vaccine Market - Competitive Landscape

10.1 India Pneumonia Vaccine Market Revenue Share, By Companies, 2024

10.2 India Pneumonia Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Asia Pacific Pneumonia Vaccine Market

Europe Pneumonia Vaccine Market

Global Pneumonia Vaccine Market

Monaco Pneumonia Vaccine Market

Mongolia Pneumonia Vaccine Market

Montenegro Pneumonia Vaccine Market

Mozambique Pneumonia Vaccine Market

Namibia Pneumonia Vaccine Market

Global Go To Market Strategy - 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here